SABCS: Imlunestrant Tied to Improved PFS for ER-Positive, HER2-Negative Breast Cancer With ESR1 Mutations
Imlunestrant leads to significantly longer progression-free survival among those with ESR1 mutations, but not in overall population
2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence
Significant increase seen in incidence rates at presentation for women overall, and for those aged 20 to 39, 40 to 74, and 75 years or older
ASH: Blinatumomab + Chemo Aids Survival in B-Cell Acute Lymphoblastic Leukemia
Estimated disease-free survival 97.5 ± 1.3 and 90.2 ± 2.3 percent with chemotherapy plus blinatumomab, chemo alone in average-risk patients
Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer
All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM
FDA Asks Biden Administration to Limit Nicotine in Tobacco Products
1990 to 2021 Saw Decline in Life Expectancy in the United States
Rankings of life expectancy and healthy life expectancy declined for males and females in the United States
Clinical Practice Guideline Updated for Radiation Therapy for Rectal Cancer
Neoadjuvant RT strongly recommended for stage II to III rectal cancer but can be omitted for those at lower risk for locoregional recurrence
Durable Response High With Obe-Cel in B-Cell Acute Lymphoblastic Leukemia
Overall remission occurred in 77 percent of patients in a cohort with morphologic disease
Prostate Cancer Incidence, Mortality Rates Mainly Stable, Decreasing
Increases seen in some countries, mostly in Africa, Asia, Latin America and the Caribbean, and Central and Eastern Europe
USPSTF Issues Draft Recommendation Statement for Cervical Cancer Screening
Screening recommended every three years with cervical cytology for women aged 21 to 29 years, every five years with hrHPV screening at age 30 to 65 years
